The Uttar Pradesh government on Sunday banned the coldrif cough syrup manufactured by Shreesan Pharmaceutical following reports of severe side effects, resulting in the death of 14 children in Madhya Pradesh.
The state's Assistant Commissioner of Drug Administration has issued instructions to all drug inspectors to collect samples of the cough syrup manufactured by Shreesan Pharmaceutical Chhindwarafrom both government and private institutions across Uttar Pradesh.
These samples will be sent to a laboratory in Lucknow for testing.
The order also prohibits the import and export of the cough syrup in government and private institutions until further notice. Authorities have emphasised strict compliance with the instructions to ensure public safety.
The officials said that the action is being taken as a precautionary measure to prevent further adverse effects and to monitor the safety of medicines circulating in the state.
Earlier in the day, Congress workers held protests in Bhopal and in Jaipur over the death of 14 children in Chhindwara, Madhya Pradesh, after allegedly consuming Coldrif Cough syrup.
In Madhya Pradesh, Congress workers protested against Deputy Chief Minister and Health Minister Rajendra Shukla, demanding his resignation. Protesters were seen with posters and banners featuring the slogans "Rajendra Shukla sharam karo, istefaa do" and "Masoom bacche ki maut ke saudagar zimmedari lo".
Concurrently, in Jaipur, Congress workers held banners with the slogan, "Nakli dawa band karo, doshiyo ke khilaaf karwayi karo, BJP sarkaar jawaab do".
Aam Aadmi Party (AAP) workers also held protests in Jaipur outside the Kaysons Pharma over the incident.
Party worker Amit Dadhich demanded that the company be shut down immediately, citing corruption and negligence. He criticised the government for allowing fake medicines to be sold, saying it's an injustice to the country and its people."Several children have lost their lives, and several children are in a serious condition, admitted in hospital and ICU after consuming the cough syrup manufactured by Kaysons Pharma...When the doctor consumed the same syrup, he fainted and had to be admitted..." Dadhich told ANI.
Earlier, the Madhya Pradesh government has announced a complete ban on the sale of the cough syrup across the state after 14 children's deaths due to kidney failure in Chhindwara.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)